Prof. Akiko Iwasaki banner
Prof. Akiko Iwasaki

Prof. Akiko Iwasaki Bluesky Profile Stats

@virusesimmunity.bsky.socialEnglish flagEnglishEducationTier B
View on Bluesky
Account age: 1 year (joined November 2024)

Prof. Akiko Iwasaki Bluesky stats, updated continuously. @virusesimmunity.bsky.social has 18,420 followers and 21 posts on Bluesky. Account age: 1 year (joined November 2024).

Followers
18K
Growth (7d)
+24
Following
287
Posts
21
Influence
242

Follower growth

2026-06-10+126 over 128 days2026-10-28

Bio

We study antiviral immunity and viral disease pathogenesis. We are developing mucosal vaccine strategies to prevent infection and transmission. #COVID19 #longCOVID #vaccines

Check Prof. Akiko Iwasaki with free tools

The same checks work on any Bluesky account. Free, no sign-up and no email.

Creator Rank, our free Chrome extension, shows this account's audience rank and Creator Score next to its name on Bluesky itself.

Prof. Akiko Iwasaki on Bluesky - frequently asked questions

How many followers does Prof. Akiko Iwasaki have on Bluesky?
Prof. Akiko Iwasaki (@virusesimmunity.bsky.social) has 18,420 followers on Bluesky. It gained 24 new followers in the last 7 days. The count is refreshed continuously from the public AT Protocol.
When did Prof. Akiko Iwasaki join Bluesky, and how old is the account?
Prof. Akiko Iwasaki joined Bluesky in November 2024. The @virusesimmunity.bsky.social account is 1 year old. Searches for Prof. Akiko Iwasaki age often mean a personal age, which we do not publish. The figure here is the account age only.
How many posts has Prof. Akiko Iwasaki published?
Prof. Akiko Iwasaki has published 21 posts on Bluesky.
Is Prof. Akiko Iwasaki verified on Bluesky?
@virusesimmunity.bsky.social does not currently show a Bluesky verification. Many real accounts on Bluesky are unverified, since verification is still rolling out.
What does Prof. Akiko Iwasaki post about?
Prof. Akiko Iwasaki is classified under Education in our directory. Bio: "We study antiviral immunity and viral disease pathogenesis. We are developing mucosal vaccine strategies to prevent infection and transmission. #COVID19 #longCOVID #vaccines ".